• CLINICAL RESEARCH – SIX HELPFUL HINTS FOR EVOLVING TRIALS (4/20/2017) by Elizabeth Gallagher - In my last blog on expanding your global grasp, we explored the prospect of expanding clinical trials to regions beyond North America and Western Europe. However, even the best plans can encounter unforeseen obstacles. Today, we’d like to relay some advice that may help you circumvent variables that could delay progress. Firstly, it’s essential to […]
  • ProSyries Pre-Filled Syringe Behind The Scenes: Dedicated Cold Chain Facility & ProSyries℠ Pre-filled Syringe Tour (4/14/2017) by Guido Hunkeler - ProSyries℠ Pre-filled Syringe Packaging and Labeling It’s always a great experience to have clients visit our facility and personally show them our latest innovations (this time in pre-filled syringes) and services. Last week I had a wonderful opportunity to do exactly that with over 30 participants at our Behind the Scenes Facility Tour, part of […]
  • CLINICAL RESEARCH – EXPANDING YOUR GLOBAL GRASP (4/6/2017) by Elizabeth Gallagher - Getting your target therapeutic to patients sooner is the objective of every pharmaceutical company. At times, Sponsor companies and investigational sites can struggle to meet their clinical trial enrollment objectives. Often delays occur because the prospective sites might be limited in North America and Western Europe. Extending the trial to include other regions might add […]
  • Cold Chain Considerations for Cell Therapy Clinical Trials (3/30/2017) by Sarah Hand - This week we welcome our guest blogger, Sarah Hand, to share her thoughts on the complexities of cell therapy from a supply chain perspective. The main thing that makes cell therapy more complex from a supply chain perspective, is the requirement to maintain the drug at cryogenic temperatures prior to dosing. Cell therapy and immunotherapy […]
  • Best Practice Guidelines for importation of controlled substances to Israel. (3/23/2017) by Angus Macleod - In last week’s blog I discussed how Israel is becoming a clinical trial powerhouse. Earlier this week Fisher Clinical Services participated in the Outsourcing in Clinical Trials Israel Conference. The objective of the conference was to provide attendees with the exclusive opportunity to discuss how they develop their outsourcing strategies & improve operational efficiency in clinical […]
  • Israel is evolving into a clinical trial powerhouse – BUT understand the regulatory processes! (3/16/2017) by Angus Macleod - Israel is evolving into a clinical trial powerhouse. Its highly skilled workforce, adherence to Good Clinical Practice (GCP) and strong patient enrolment and retention rates make this a country of interest for clinical research. However, I have one top tip for you – when considering the best way to import clinical trial materials to Israel, […]
  • How US Drug Supply Chain Security Act Impacts Comparator Sourcing (3/9/2017) by Jürgen Karg - In a recent audit a new supplier was not qualified as compliant according to the Drug Supply Chain Security Act (DSCSA). This provider was declined by Fisher Clinical Services as a new supplier of comparator drugs (subsequently named reference drugs) for clinical trials. I would like to dedicate my blog today to “the positive impact […]
  • 7 THINGS TO KNOW ABOUT BIOSIMILAR DRUGS (3/2/2017) by Emilie Liadis - This week we welcome our guest blogger, Emilie Liadis, to share her thoughts on biosimilars. As discussed on the Doe & Ingalls blog* Citigroup estimates that biosimilars could reach $110 billion in global market share by 2025, and some prescription benefit managers such as Express Scripts have already signaled their intent to adopt early, citing over $250 […]
  • Cool and controlled – how EU guidelines impact shipments (2/23/2017) by Alex Guillen - A patient’s well-being ultimately overrides any concerns about cost-efficiency across the clinical supply chain. But as EU guidelines become increasingly demanding in terms of protection of IMP and liability, biotech and pharmaceutical companies are discussing whether to invest in controlling or monitoring their shipments. The revised regulations have made this question more pertinent, as they […]
  • Introducing the New ProSyries℠ Pre-Filled Syringe & Labeling System 2-25C (2/17/2017) by Guido Hunkeler - Fisher Clinical Services is proud to introduce its latest innovation in pre-filled syringe assembly and labeling. Now, labeling and secondary packaging of pre-filled syringes by fully automated, quality-driven, proprietary process and technology is available under both cold (2C to 25C) and ambient conditions. Capacity is 1,800 prefilled syringes per hour for a maximum yield of […]